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INTRODUCTION
Hyperaldosteronism as a secondary cause of hypertension
has been well known. However, the metabolic effects of this
condition and its association with parathyroid hormone in
causing a pro-inflammatory state in the body have been rec-
ognized only recently (1, 2). Aldosterone-salt treatment
(AldoST) in rats, similarly chronic mineralocorticoid excess
states in humans, is known to cause a fall in plasma concen-
trations of ionized Ca
2+ and Mg
2+ by increased urinary and
fecal excretion of these divalent cations (3, 4). The resulting
secondary hyperparathyroidism is thought to play a signifi-
cant role in the patho-physiology associated with this con-
dition.
CASE REPORT
A 28-yr-old college lecturer from interior southern India,
had complaints of polyuria since November 2001. Polyuria
was noticed only in recumbent position irrespective of the
time of the day. She first consulted an urologist, who diag-
nosed nephrolithiasis for which she underwent extracorpo-
real short wave Lithotripsy (ESWL). At that time she was
detected to have a blood pressure of 170/90 mmHg and also
noted to have spasms of the upper limb while recording the
blood pressure. She was examined by the local physician who
diagnosed hypertension and started her on amlodipine. Blood
chemistries done at that time including calcium and phos-
phorus were normal and potassium was 3.56 mM/L (3.5-5).
Her urinary symptoms continued to persist despite treatment.
In 2003 she became pregnant and carried through the preg-
nancy well until 32 weeks. Pregnancy had to be terminated
with a caesarean section when it became increasingly difficult
to control her blood pressure. After delivery she started having
severe cramps in both upper and lower limbs. An endocrinol-
ogy consultation was sought in 2004 for recurrent cramps, a
thorough work up was done and results are shown in Table 1.
Since no obvious cause for hypocalcemia was found, an
intrinsic calcium absorption defect was suspected and patient
was advised six grams of calcium orally, without any symp-
tomatic improvement. In the subsequent months, atenolol,
losartan and prazosin were all added, at different times, in
order to control the blood pressure. 
She was first seen in our institution in April 2005 with the
above described complaints in the urology department. She
had a significant weight loss of 12 kg in the past year. She
had never smoked cigarettes or consumed alcohol. None of
the family members were hypertensive or had adrenal or other
endocrine tumors. 
Her physical examination revealed a blood pressure of 150/
90 mmHg, without any postural variation. Carpal spasm was
noticed when blood pressure was being taken. Pulse rate was
80/min and respiratory rate was 18/min. She was 165 cm tall
and weighed 64 kg. Systemic examination was unremark-
able. A complete urological work up including plain abdom-
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Symptomatic Hypocalcemia in Primary Hyperaldosteronism:
A Case Report
The metabolic alterations caused by hyperaldosteronism are being increasingly
recognized and have generated considerable interest among the medical fraterni-
ty. Hyperaldosteronism is suspected to have a pivotal role in the patho-physiology
of congestive cardiac failure where it has been studied extensively. But its effects
on calcium metabolism, parathyroid metabolism and renal handling of calcium are
less well described. Recent experimental models have shed light into the roles played
by previously unknown mechanisms in causing these metabolic alterations. We
hereby report a case of primary hyperaldosteronism due to adrenal adenoma (Conn’s
syndrome) who presented with a myriad of clinical features including symptomatic
hypocalcemia, significant weight loss along with uncontrolled hypertension for a
prolonged period before eventually detected to have primary hyperaldosteronism.
Surgical removal of the causative tumor resulted in prompt disappearance of all
the symptoms and signs and regain of lost weight.  
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inal radiography, intra venous pyelography, micturating cys-
tourethrogram were all done which failed to explain her symp-
toms. Simultaneously she was being worked up for secondary
causes of hypertension. The results of the investigations are
shown in Table 2.
Sonography of the abdomen had revealed multiple hyper-
echoeic foci with shadowing in the right kidney, mild hep-
atomegaly measuring 15 cm with normal echotexture and a
well defined hypoechoeic lesion measuring about 3×3×3 cm
in the left suprarenal region. Bilateral renal Doppler showed
few renal indices in the upper limit of the normal. Hence
renal artery stenosis was ruled out with renal angiogram. Serum
aldosterone in standing position was elevated at 318.94 ng/L
(5-41). Electrocardiography showed left ventricular hyper-
trophy with strain pattern while 2D Echocardiography re-
vealed slight enlargement of the left ventricular chamber with
a normal ejection fraction and mild Mitral regurgitation. A
computed tomography scan of abdomen confirmed a well
defined exophytic mass lesion (3×2.8×2.8 cm) from the
left adrenal mass (Fig. 1).
Patient was optimized for surgery with multiple antihy-
Calcium total 7.3 mg/dL (8.5-10.5)
Calcium (ionized) 3.50 mg/dL (4.5-5.3)
Phosphorus 3.4 mg/dL (2.48-4.34)
Alkaline phosphatase 75 IU/L (40-125)
24 hr urine volume  2,300 mL
24 hr urinary calcium 193.20 mg/day (100-300)
24 hr urinary phosphorus 2.070 gm/day (0.4-1.3)
Parathyroid hormone (intact) 91.2 pg/mL (14-72)
25-Hydroxyvitamin D 14.9 ng/mL (9-37.6)
Table 1. Biochemical investigations done in 2004 for work up
of hypocalcemia done elsewhere (values in parenthesis indi-
cate normal range)
Fasting blood glucose 114 mg/dL (75-110)
Serum Sodium 141 meq/L (136-146)
Serum Potassium 2.1 meq/L (3.5-5)
Serum Calcium (total) 7.4 mg/dL (8.7-10.2)
Phosphate 3.6 mg/dL (2.5-4.3)
Albumin 4.2 g/dL (3.5-5.5)
Urea  16 mg/dL (8-35)
Creatinine 0.7 mg/dL (0.6-1.6)





Serum cortisol (12 AM sample) 11.6 mcg/dL (0-10)
Serum cortisol (8 AM sample) 17.6 mcg/dL (5-25)
Serum Magnesium 1.3 mg/dL (1.5-2.3)
24 hr urine Volume 4,400 mL
24 hr urine VMA 3.6 mg/day (<6)
24 hr urine17-ketosteroid  5.3 mg/day (3-12)
Serum Cholesterol 118 mg/dL
Serum triglyceride 65 mg/dL
Serum HDL 36 mg/dL
Serum LDL 69 mg/dL
Serum T3 1.2 ng/mL (0.8-2)
Serum T4 15.1 mcg/dL (5-12)
Serum TSH 3.2 mIU/L (0.3-5)
Table 2. Results from biochemical investigations in our institu-
tion during admissions
Fig. 1. (A) Plain computed tomography image of the abdomen showing a mass measuring 3×3×3 cm in the supra renal region on the
left side (arrow). (B) Contrast CT of the same region showing a non enhancing nature of the mass lesion in the same area.
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pertensive drugs including spironolactone, atenolol and
amlodipine with which stable blood pressure control was
achieved. She underwent left adrenalectomy under general
anesthesia and the exophytic mass was resected. Patient tol-
erated the procedure well and made a good post operative
recovery. Operative specimen and histopathology was con-
sistent with adrenal adenoma (Fig. 2, 3).
Her blood pressure started normalizing and her anti-hyper-
tensive medications were gradually tapered. At follow-up
after 6 weeks patient was off antihypertensive medication
and blood pressure was normal. Her repeat biochemistries
revealed potassium of 4.3 meq/L and calcium of 9.7 mg/dL
(8.7-10.2). She did not have cramps and had regained 12 kg.
At one year follow-up, she has regained her pre-morbid weight
and continues to be normotensive and symptom free. 
DISCUSSION
The syndrome of primary aldosteronism, first described by
Conn (5) in 1955, is characterized by hypertension, hypo-
kalemia, suppressed plasma rennin activity, and increased
aldosterone excretion. Hypertension is caused by excessive
sodium retention and body fluid expansion mediated by the
aldosteronism. Hypokalemia results from the urinary loss of
potassium, because it is exchanged for sodium in the distal
renal tubule under the influence of aldosterone. Volume ex-
pansion and sodium retention cause inhibition of renal release
of renin, which leads to low plasma renin activity. If hypo-
kalemia is severe, it may cause muscle weakness, cramps, or
even paralysis.
Our case is unique because this patient presented with
almost entire constellation of symptoms and metabolic effects
described in aldosterone excess state. Although the diagno-
sis remained obscure for more than two years until it finally
unveiled itself. Association of hyperaldosteronism with renal
calculi is known and has been reported earlier (6). Postural
variation in urine output was quite characteristic in our pa-
tient. Previous study has described a small subgroup of pri-
mary aldosteronism, named aldosterone-producing renin-
responsive adenoma (AP-RA), have significant postural vari-
ation in concentration of aldosterone levels when subjected
to upright posture. This might partially explain her symp-
tom of supine polyuria (7).
Urinary calcium excretion was normal in our patient, but
24 hr urinary phosphate excretion was high. Increased uri-
nary calcium excretion in PA has been noted only at an ele-
vated sodium intake (8). The probable mechanism is thought
to be related to expansion of the extravascular space, result-
ing in decreased proximal tubular reabsorption and thereby
increased distal delivery of Na
+, Mg
2+, Ca
2+, with the miner-
alocorticoid promoting distal tubular Na
+ reabsorption with-
out retarding magnesium or calcium excretion (3). While
increased phosphate excretion could be due to ensuing sec-
ondary hyperparathyroidism due to hypocalcemia. Howev-
er, sodium intake was not standardized while measuring the
24 hr urinary calcium excretion in our patient. 
In one study, patients with PA were detected to have signif-
icantly higher concentration of parathyroid hormone (PTH)
compared to both normal and essential hypertensive subjects,
consistent with our case (2). Severe weight loss due to hyper-
aldosteronism has been reported earlier (9, 10). Aldostero-
nism, by causing secondary hyperparathyroidism, is thought
to cause a pro-inflammatory state characterized by oxidative
stress, immune cell activation, vascular remodeling by invad-
ing inflammatory cells, and bone loss (1). This effect has been
studied in the setting of secondary hyperaldosteronism asso-
ciated with cardiac failure and cachexia (11). We feel that
Fig. 2. Gross operative specimen showing a 3×3 cm exophytic
adrenal mass excised from the left suprarenal area.
Fig. 3. Microscopy after HE stain showing rounded lipid rich clear
cells resembling those of normal zona fasciculate.Metabolic Changes in Hyperaldosteronism-An Illustrated Case Report 1223
further insight needs to be shed into this effect of hyperal-
dosteronism and the mechanism by which it causes weight
loss needs to be elucidated.
Primary hyperaldosteronism represents one of the few
treatable causes of hypertension. In addition to hypertension
which is often difficult to control it may manifest through
symptoms and signs due to its various metabolic effects. A
high index of suspicion and a systematic approach is instru-
mental in identifying and proving the diagnosis. Patients in
whom aldosteronomas are identified should be subjected to
surgery which can be curative.
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